Icrucumab

DB14824Investigational

Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).

Mechanism: Pharmacologically active on Vascular endothelial growth factor receptor 1
Curator reviewed
Also known as: IMC-18F1

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Icrucumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.